Balasa, Jovine K.

HRN: 05-19-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2026
CEFUROXIME 500MG (TAB)
05/10/2026
05/16/2026
PO
500
BID
Prom X 38hrs
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines